A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 23, Issue 9, Pages 2257-2276
Publisher
Springer Nature
Online
2012-03-21
DOI
10.1007/s00198-012-1958-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison of case-finding strategies in the UK for the management of hip fractures
- (2012) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2011) Adolfo Díez-Pérez et al. BONE
- Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features
- (2011) Andrea Giusti et al. BONE
- FRAX® with and without Bone Mineral Density
- (2011) John A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
- (2011) Laura Y. Park-Wyllie JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture
- (2011) Edward S. Leib et al. JOURNAL OF CLINICAL DENSITOMETRY
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidance for the adjustment of FRAX according to the dose of glucocorticoids
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk assessment without bone density measurement in routine clinical practice
- (2011) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis: burden, health care provision and opportunities in the EU
- (2011) O. Ström et al. Archives of Osteoporosis
- Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
- (2010) Inès Losada et al. AUTOIMMUNITY REVIEWS
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- (2010) A. Papaioannou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid
- (2010) Takao Sugiyama et al. Gender Medicine
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007
- (2010) Zhong Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
- (2010) A. Catharine Ross et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of glucocorticoid-induced osteoporosis
- (2010) Juliet Compston Nature Reviews Rheumatology
- Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
- (2010) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
- (2010) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis
- (2009) Raz Yirmiya et al. BIOLOGICAL PSYCHIATRY
- Which Women Should Be Selected for Vertebral Fracture Assessment? Comparing Different Methods of Targeting VFA
- (2009) Edward T. Middleton et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series
- (2009) Reina Armamento-Villareal et al. CALCIFIED TISSUE INTERNATIONAL
- Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells
- (2009) Wendy Mak et al. CALCIFIED TISSUE INTERNATIONAL
- Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates
- (2009) Kuntheavy Ing-Lorenzini et al. DRUG SAFETY
- Timing of Repeat BMD Measurements: Development of an Absolute Risk-Based Prognostic Model
- (2009) Steven A Frost et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for Osteoporosis
- (2009) Nelson B Watts et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular Diseases
- (2009) Ichiro Tatsuno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate-Related Osteonecrosis of the Jaws: A Single-Center Study of 101 Patients
- (2009) Towy Sorel Lazarovici et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
- (2009) S. A. STOCH et al. JOURNAL OF RHEUMATOLOGY
- Bisphosphonate Associated Osteonecrosis of the Jaw
- (2009) A. A. KHAN et al. JOURNAL OF RHEUMATOLOGY
- Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center
- (2009) Adi Cohen et al. JOURNAL OF WOMENS HEALTH
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
- (2009) J. Compston et al. MATURITAS
- Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
- (2009) Lorenz C. Hofbauer et al. MOLECULAR ENDOCRINOLOGY
- FRAX® assessment of osteoporotic fracture probability in Switzerland
- (2009) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
- (2009) H. Kaji et al. OSTEOPOROSIS INTERNATIONAL
- The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
- (2009) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
- (2009) T. Beukelman et al. OSTEOPOROSIS INTERNATIONAL
- Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?
- (2009) M. H. Edwards et al. OSTEOPOROSIS INTERNATIONAL
- Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
- (2009) B. L. Langdahl et al. OSTEOPOROSIS INTERNATIONAL
- BMD, clinical risk factors and their combination for hip fracture prevention
- (2009) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral
- (2009) J. González Macías et al. REVISTA CLINICA ESPANOLA
- Pregnancy outcome following in utero exposure to bisphosphonates
- (2008) Shirley Levy et al. BONE
- Glucocorticoid Excess Affects Cortical Bone Geometry in Premenopausal, but not Postmenopausal, Women
- (2008) Hiroshi Kaji et al. CALCIFIED TISSUE INTERNATIONAL
- Role of Gap Junction, Hemichannels, and Connexin 43 in Mineralizing in Response to Intermittent and Continuous Application of Parathyroid Hormone
- (2008) Priscilla P. Cherian et al. CELL COMMUNICATION AND ADHESION
- Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
- (2008) Feng-Sheng Wang et al. ENDOCRINOLOGY
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
- (2008) Ernest Beng Kee Kwek et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
- (2008) Lilian I Plotkin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Severely Suppressed Bone Turnover and Atypical Skeletal Fragility
- (2008) Maja Visekruna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Revised Clinician’s Guide to the Prevention and Treatment of Osteoporosis
- (2008) Bess Dawson-Hughes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alendronate Protects Premenopausal Women from Bone Loss and Fracture Associated with High-dose Glucocorticoid Therapy
- (2008) Yosuke Okada et al. JOURNAL OF RHEUMATOLOGY
- A Comparison of Calcium, Calcitriol, and Alendronate in Corticosteroid-Treated Premenopausal Patients with Systemic Lupus Erythematosus
- (2008) Swan S. Yeap et al. JOURNAL OF RHEUMATOLOGY
- Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
- (2008) S. Fujiwara et al. OSTEOPOROSIS INTERNATIONAL
- Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
- (2008) J. Compston et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- (2008) A. N. A. Tosteson et al. OSTEOPOROSIS INTERNATIONAL
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- (2008) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- The incidence and risk of hip fracture in Poland
- (2008) E. Czerwinski et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The cost-effectiveness of alendronate in the management of osteoporosis
- (2007) John A. Kanis et al. BONE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now